[1]
2025. CHITOSAN-COATED GOLD NANOPARTICLES FOR TARGETED DELIVERY OF DOXORUBICIN IN LIVER CANCER THERAPY. The Research of Medical Science Review. 3, 10 (Oct. 2025), 103–115.